Targeting discovery is an important frontier in the fight against pancreatic cancer. Take a look at this example of how Tempus Multimodal Database enabled a pharmaceutical company to more quickly identify pancreatic cancer subtypes’ molecular signatures.
Thank you for contacting Tempus. We will respond shortly.
You do not qualify for this content, if you have any questions please reach out to our team.